| Popis: |
Transfusion support in cancer patients is vital for their survival. Platelets, in particular, are necessary to prevent serious bleeding. The need for blood components for oncology patients is small compared with the need of patients with hematologic malignancies. The subject is important because the use of these valuable components is dependent on a limited supply and availability. The risks from transfusion must always be considered. Fortunately, with increased monitoring of the blood supply, they have been reduced. Transfusion should always be used prudently. |
